Company Profile

PedialyDx Inc
Profile last edited on: 10/17/23      CAGE: -----      UEI: UKFQJ3MSYJF1

Business Identifier: Acoustic analysis of infant cry: advanced analysis and insight.
Year Founded
----
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

704 N King Street Suite 500
Wilmington, DE 19801
   (216) 406-6149
   N/A
   N/A
Location: Single
Congr. District: 00
County: New Castle

Public Profile

Structured around using machine learning and advanced acoustic analysis techniques to quantify the acoustics of a baby cry, PedialyDx Inc. was formed to commercialize technology derived from research at Brown University and Women & Infants Hospital that has demonstrated that the acoustics of an infant’s cry can indicate the immediate and long-term developmental outcome of the baby. PedialyDx is developing products to improve assessment and diagnosis of babies. PedialyDx uses Machine Learning and advanced acoustic analysis techniques to quantify acoustics of baby cry.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NIH $1,834,156
Project Title: Diagnosis of Neonatal Opioid Withdrawal Syndrome (NOWS) and development of a NOWS-App

Key People / Management

  Peter O'Neill -- CEO

  Brian Beckrest -- VP Product Development

  Barry Lester -- Advisor

  Stephen Sheinkopf -- Advisor

Company News

There are no news available.